Cite
High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.
MLA
Deconinck, Eric, et al. “High-Dose Therapy Followed by Autologous Purged Stem-Cell Transplantation and Doxorubicin-Based Chemotherapy in Patients with Advanced Follicular Lymphoma: A Randomized Multicenter Study by GOELAMS.” Blood, vol. 105, no. 10, May 2005, pp. 3817–23. EBSCOhost, https://doi.org/10.1182/blood-2004-10-3920.
APA
Deconinck, E., Foussard, C., Milpied, N., Bertrand, P., Michenet, P., Cornillet-LeFebvre, P., Escoffre-Barbe, M., Maisonneuve, H., Delwail, V., Gressin, R., Legouffe, E., Vilque, J.-P., Desablens, B., Jaubert, J., Ramee, J.-F., Jenabian, A., Thyss, A., Le Pourhiet-Le Mevel, A., Travade, P., … Colombat, P. (2005). High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS. Blood, 105(10), 3817–3823. https://doi.org/10.1182/blood-2004-10-3920
Chicago
Deconinck, Eric, Charles Foussard, Noel Milpied, Philippe Bertrand, Patrick Michenet, Pascale Cornillet-LeFebvre, Martine Escoffre-Barbe, et al. 2005. “High-Dose Therapy Followed by Autologous Purged Stem-Cell Transplantation and Doxorubicin-Based Chemotherapy in Patients with Advanced Follicular Lymphoma: A Randomized Multicenter Study by GOELAMS.” Blood 105 (10): 3817–23. doi:10.1182/blood-2004-10-3920.